Connect Biopharma Completes Enrollment of CBP-201 Global Phase 2 Clinical Trial in…
Connect Biopharma Holdings Limited, a global clinical-stage biopharmaceutical company dedicated to improving the lives of patients with chronic inflammatory diseases through the development of therapies derived from T cell-driven research,…